Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-21-000600
Filing Date
2021-03-17
Accepted
2021-03-17 16:15:47
Documents
86
Period of Report
2021-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmmj_10q.htm 10-Q 754111
2 EX-31.1 bmmj_ex311.htm EX-31.1 9718
3 EX-31.2 bmmj_ex312.htm EX-31.2 9763
4 EX-32.1 bmmj_ex321.htm EX-32.1 4449
  Complete submission text file 0001640334-21-000600.txt   6953355

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmmj-20210131.xml EX-101.INS 1359958
6 XBRL TAXONOMY EXTENSION SCHEMA bmmj-20210131.xsd EX-101.SCH 120266
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmmj-20210131_cal.xml EX-101.CAL 60116
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmmj-20210131_def.xml EX-101.DEF 282746
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmmj-20210131_lab.xml EX-101.LAB 1096143
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmmj-20210131_pre.xml EX-101.PRE 444172
Mailing Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6
Business Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6 604-376-3567
BODY & MIND INC. (Filer) CIK: 0001715611 (see all company filings)

EIN.: 981319227 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55940 | Film No.: 21750725
SIC: 2834 Pharmaceutical Preparations